Gammamed Plus High Dose Rate Remote Afterloading System
by Gammamed USA
510(k) K983436
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK983436 | Date29 Oct 1998 | StatusActive |
Recalls
-
- Terminated Z-0607-2013
The guide tube which is part of the Segmented Cervix Applicator Set is difficult to disconnect from cervical sleeve.
-
- Terminated Z-2997-2011
- Terminated Z-2995-2011
- Terminated Z-2998-2011
- Terminated Z-2999-2011
- Terminated Z-3000-2011
- Terminated Z-2996-2011
Potential of weld failure of the Titanium intrauterine probe at the cervical stopper.
-
- Terminated Z-3013-2011
Certain GammaMed Flexible applicator probes may not have been heat annealed during manufacturing to prevent shrinkage after autoclave.
-
- Terminated Z-2993-2011
- Terminated Z-2991-2011
- Terminated Z-2992-2011
Needle tip may separate from the needle shaft such that the tip may detach in the patient upon withdrawal.
-
- Terminated Z-0327-2012
- Terminated Z-0326-2012
- Terminated Z-0328-2012
Plastic needle tip could possibly crack or separate.
-
- Terminated Z-0295-2012
GammaMed Flexible Applicator Probes may not have been heat annealed during manufacturing to prevent shrinkage after autoclave.
-
- Terminated Z-1268-06
Medical device software for brachytherapy may cause erroneous data to be recorded and affect patient radiation treatments. Erroneous data may be listed on the treatment history report, and the default step size may lead to a misadministration if treatment data is entered manually.
-
- Terminated Z-0921-05
A defective treatment applicator in a cancer therapy medical device may become separated potentially causing patient injury.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JAQ
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.5700
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent